期刊
ONCOGENE
卷 34, 期 47, 页码 5771-5780出版社
SPRINGERNATURE
DOI: 10.1038/onc.2015.85
关键词
-
资金
- Uniting Against Lung Cancer
- National Cancer Institute [1R01CA166376, 1R21CA170537, 1R01CA191489]
Lung cancer encompasses a heterogeneous group of malignancies. Here we discuss how the remarkable diversity of major lung cancer subtypes is manifested in their transforming cell of origin, oncogenic dependencies, phenotypic plasticity, metastatic competence and response to therapy. More specifically, we review the increasing evidence that links this biological heterogeneity to the deregulation of cell lineage-specific pathways and the transcription factors that ultimately control them. As determinants of pulmonary epithelial differentiation, these poorly characterized transcriptional networks may underlie the etiology and biological progression of distinct lung cancers, while providing insight into innovative therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据